Clinical and Serologic Features in Patients With Incomplete Lupus Classification Versus Systemic Lupus Erythematosus Patients and Controls

ConclusionAlthough usually characterized by milder symptoms, ILE manifestations may require immunomodulatory treatments. Longitudinal studies are necessary to understand how ILE affects organ damage and future SLE risk, and to delineate molecular pathways unique to ILE.

Source: Arthritis Care and Research - November 14, 2017 Category: Rheumatology Authors: Teresa Aberle, Rebecka L. Bourn, Melissa E. Munroe, Hua Chen, Virginia C. Roberts, Joel M. Guthridge, Krista Bean, Julie M. Robertson, Kathy L. Sivils, Astrid Rasmussen, Meghan Liles, Joan T. Merrill, John B. Harley, Nancy J. Olsen, David R. Karp, Judith Tags: Original Article Source Type: research